BHVN
Biohaven Pharmaceutical Holding Co Ltd
NYSE: BHVN · HEALTHCARE · BIOTECHNOLOGY
$9.59
+4.24% today
Updated 2026-04-30
Market cap
$1.38B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.86
Dividend yield
—
52W range
$7 – $24
Volume
2.2M
Biohaven Pharmaceutical Holding Co Ltd (BHVN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-94.81M | $-197.14M | $-377.33M | $-75.96M | $-145.84M | $-297.69M | $-331.73M | $-582.45M | $-609.44M |
| Capital expenditures | $541000.00 | $4.17M | $2.53M | $2.70M | $938000.00 | $41.07M | $3.05M | $4.05M | $715000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $13.24M | $16.93M | $54.97M | $29.50M | $65.64M | $193.56M | $28.79M | $71.96M | $112.36M |
| Free cash flow | $-95.36M | $-201.31M | $-379.87M | $-78.65M | $-146.78M | $-338.76M | $-334.77M | $-586.50M | $-610.15M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $40.30M | — | — | — | — |